Compile Data Set for Download or QSAR
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 12307
TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694495(US20240293557, Compound SF-8-140)
Affinity DataIC50: 1.66nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM50113281(AT-7519 | US20240293557, Compound AMC-3-098 | US12...)
Affinity DataIC50: 2.06nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694490(US20240293557, Compound AMC-3-104)
Affinity DataIC50: 2.82nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694494(US20240293557, Compound CG-3-071)
Affinity DataIC50: 2.85nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694491(US20240293557, Compound AMC-3-106)
Affinity DataIC50: 3.04nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694492(US20240293557, Compound CG-3-066)
Affinity DataIC50: 3.32nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694493(US20240293557, Compound CG-3-067)
Affinity DataIC50: 3.89nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694489(US20240293557, Compound AMC-3-097)
Affinity DataIC50: 3.96nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694496(US20240293557, Compound SF-8-141)
Affinity DataIC50: 4.49nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694488(US20240293557, Compound AMC-3-086)
Affinity DataIC50: 11nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 9(Human)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM694487(US20240293557, Compound AMC-3-095)
Affinity DataIC50: 11.3nMAssay Description:CDK9 activity assays were performed by Nanosyn using a microfluidics mobility shift platform. In this assay, a fluorescently labeled substrate is inc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent